Menu

• Ask a Health Expert about COOMBS DIRECT TEST POSITIVE
• Post Your Side Effect related to COOMBS DIRECT TEST POSITIVE
• COOMBS DIRECT TEST POSITIVE and FDA Warnings
• COOMBS DIRECT TEST POSITIVE in Patients Wiki
• Report COOMBS DIRECT TEST POSITIVE in Drug Side Effect Survey

COOMBS DIRECT TEST POSITIVE side effect

What is COOMBS DIRECT TEST POSITIVE ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Winrho Side Effects Report #5623963-5
Health Professional from UNITED STATES reported WINRHO SDF problem on Jan 02, 2008. Male patient, 26 years of age, weighting 211.0 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: coombs direct test positive, disseminated intravascular coagulation, haemolysis, renal failure, . WINRHO SDF dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient died on 03/08/2007.

Gamunex Side Effects Report #5489002-4
GAMUNEX problem was reported by a Consumer or non-health professional from CANADA on Oct 08, 2007. Female patient, child 10 years of age, weighting 66.14 lb, was treated with GAMUNEX. After drug was administered, patient experienced the following problems/side effects: coombs direct test positive, haemoglobin decreased, haemolysis, . GAMUNEX dosage: unknown. During the same period patient was treated with CLINDAMYCIN, CEFOTAXIME, RANITIDINE, ONDANSETRON, VITAMIN K, ALDACTAZIDE, FUROSEMIDE, TYLENOL. Patient recovered.

Winrho Side Effects Report #5489003-6
Physician from TURKEY reported WINRHO SDF problem on Sept 11, 2007. Male patient, 16 years of age, weighting 176.4 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with WINRHO SDF. After drug was administered, patient experienced the following problems/side effects: condition aggravated, coombs direct test positive, haemoglobinaemia, haemoglobinuria, intravascular haemolysis, neutropenia, pyrexia, rash, renal impairment, . WINRHO SDF dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5447451-4
REVLIMID problem was reported by a Physician from AUSTRIA on Aug 28, 2007. Female patient, 67 years of age, weighting 167.6 lb, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, coombs direct test positive, coombs indirect test positive, haemolysis, . REVLIMID dosage: 10 MG, DAILY, ORAL. During the same period patient was treated with ENOXAPARIN NATRIUM, LMW HEPARIN, LOVENOX. Patient recovered.


Albuminar Side Effects Report #5625201-6
Consumer or non-health professional from CANADA reported ALBUMINAR problem on Jan 23, 2008. Female patient, 74 years of age, was diagnosed with hypoalbuminaemia and was treated with ALBUMINAR. After drug was administered, patient experienced the following problems/side effects: body temperature increased, cardio-respiratory arrest, coombs direct test positive, coronary artery insufficiency, oxygen saturation decreased, . ALBUMINAR dosage: 1100 ML;TOTAL;IV. Patient died.

Levofloxacin Side Effects Report #5734412-0
LEVOFLOXACIN problem was reported by a Pharmacist from UNITED STATES on May 08, 2008. Male patient, 56 years of age, weighting 176.0 lb, was diagnosed with epididymitis and was treated with LEVOFLOXACIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, chromaturia, coombs direct test positive, haematocrit decreased, haemoglobin decreased, lethargy, macrocytosis, red cell distribution width increased, skin discolouration, . LEVOFLOXACIN dosage: 500 MG DAILY PO. Patient was hospitalized. Patient recovered.

Carmustine Side Effects Report #5330056-3
Health Professional from UNITED KINGDOM reported CARMUSTINE problem on May 17, 2007. Female patient, 41 years of age, was diagnosed with stem cell transplant, prophylaxis and was treated with CARMUSTINE. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, autoimmune thrombocytopenia, coombs direct test positive, jaundice, polychromasia, reticulocytosis, spherocytic anaemia, . CARMUSTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, MELPHALAN, CYTARABINE, MABCAMPATH, CYCLOSPORINE, METHOTREXATE. Patient recovered.